检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:曹思思[1,2,3] 邓阳[1,4] 蔡骅琳[1,2] 侯振彦 颜苗[1,2] 张毕奎[1,2]
机构地区:[1]中南大学湘雅二医院药学部,湖南长沙410011 [2]中南大学临床药学研究所,湖南长沙410011 [3]中南大学药学院,湖南长沙410013 [4]湖南中医药大学药学院,湖南长沙410028
出 处:《Journal of Chinese Pharmaceutical Sciences》2017年第4期291-297,共7页中国药学(英文版)
基 金:supported by Institute of Clinical Pharmacy,Central South University,Changsha,China
摘 要:In the present study, we determined the pharmacokinetics and bioequivalence of two amlodipine tablets in Chinese male and female volunteers using HPLC-MS/IVIS method. A randomized, two-period and crossover design was conducted in 20 healthy volunteers (14 male subjects and six female subjects). A single dose of either the reference or test formulation was given at the start of each period. Blood samples were collected before drug administration and at 1, 2, 3, 4, 5, 6, 8, I0, 12, 24, 48, 72, 96, 120 and 144 h after drug administration. Plasma amlodipine was detected by HPLC-MS/MS method, and the pharmacokinetic parameters were analyzed using DAS 3.2.8. The developed HPLC-MS/MS method was suitable for the analysis of amlodipine in biological matrix samples. The main pharmacokinetic parameters between the trial preparation and the reference preparation met the regulatory criteria for bioequivalence, and the two preparations were both well tolerated.本文采用高效液相色谱-串联质谱法(HPLC-MS/MS)研究两种氨氯地平片在健康人体内的药动学及生物等效性。采用随机双周期交叉实验设计,20名健康受试者(14名男性,6名女性),每周期单剂量口服10 mg氨氯地平片受试制剂或参比制剂后,于服药前和服药后1、2、3、4、5、6、8、10、12、24、48、72、96、120和144 h各抽取静脉血4 m L。采用优化后的高效液相色谱-串联质谱法(HPLC-MS/MS)测定氨氯地平的血药浓度,用DAS 3.2.8药动学软件求算药动学参数。20名受试者全部完成试验,受试制剂和参比制剂的主要药动学参数如下:t_(max)分别为(5.7±2.4)和(5.3±0.9)h,C_(max)分别为(6.6±1.3)和(6.6±1.9)ng/m L,AUC_(0–144)分别为(281.5±75.9)和(289.3±77.9)ng·h/m L,AUC_(0–∞)分别为(309.3±84.6)和(321.3±88.2)ng·h/m L,t_(1/2)分别为(41.1±11.0)和(43.7±13.7)h。C_(max),AUC_(0–144)和AUC_(0–∞)经对数转换后90%置信区间分别为91.8%–111.2%,94.6%–102.5%,93.9%–101.8%,满足生物等效性分析的要求。整个试验过程中,无严重不良反应发生。本试验建立的HPLC-MS/MS法适用于生物样本的分析。试验制剂和参比制剂的主要药动学参数满足生物等效性分析的要求。
关 键 词:AMLODIPINE PHARMACOKINETICS BIOEQUIVALENCE TOLERABILITY HPLC-MS/MS
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3